Koers CVR Medical Corp. BOERSE MUENCHEN
Aandelen
B3BN
CA1266321084
Biotechnologie & Medisch Onderzoek
Real Time
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,015 EUR | -9,09% |
|
-9,09% | -42,31% |
Omzet 2020 | - | Omzet 2021 | - | Marktkapitalisatie | 3,6 mln. 3,31 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | - 0 | Nettowinst (verlies) 2021 | -1 mln. -919K | EV/omzet 2020 | - |
Nettoschuld 2020 | 360K 331K | Nettoschuld 2021 | 434K 399K | EV/omzet 2021 | - |
K/w-verhouding 2020 |
-11,5
x | K/w-verhouding 2021 |
-1,55
x | Werknemers | - |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 87,21% |
1 dag | -9,09% | ||
Lopende maand | -42,31% | ||
Lopend jaar | -42,31% |
![Extreem 0.001](/images/extremecours_fleche.png)
![Extreem 0.001](/images/extremecours_fleche.png)
![Extreem 0.001](/images/extremecours_fleche.png)
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Rhodes
CEO | Chief Executive Officer | - | 20-01-21 |
Paul S. Blunden
PSD | President | - | 20-10-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Paul S. Blunden
PSD | President | - | 20-10-16 |
Phillip Bendick
BRD | Director/Board Member | - | 13-02-20 |
Joseph Lynch
BRD | Director/Board Member | - | 17-02-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-34,85% | 8,68 mld. | |
+22,85% | 3,86 mld. | |
+13,65% | 2,43 mld. | |
-26,46% | 1,84 mld. | |
-11,38% | 1,73 mld. | |
+36,95% | 1,16 mld. | |
+51,25% | 842 mln. | |
-9,17% | 702 mln. | |
-11,12% | 594 mln. |
- Beurs
- Aandelen
- Koers CVM.H
- Koers B3BN